Professor | Shanxi Medical University | China
Prof. Kaiming Zhang is a researcher affiliated with Shanxi Medical University, Taiyuan, China, recognized for his expanding contributions to contemporary biomedical and clinical research. With 111 scientific publications, 896 citing documents, and over 1,300 citations, he has established a sustained scholarly presence reflected in an h-index of 22, demonstrating both productivity and the growing influence of his work. Dr. Zhang’s research portfolio spans multidisciplinary domains within medical science, contributing to the advancement of evidence-based understanding in areas relevant to public health, disease mechanisms, and clinical outcomes. His publications include peer-reviewed journal articles, emerging preprints, and collaborative studies with more than 120 co-authors, underscoring his strong integration within global scientific networks and cross-institutional partnerships. Through this collaborative engagement, Dr. Zhang actively supports the development of innovative methodologies, robust analytical frameworks, and data-driven insights that inform clinical practice and medical policy. His contributions are widely cited, reflecting their relevance across diverse research communities and their application in ongoing scientific progress. Dr. Zhang’s scholarly activities also demonstrate a commitment to scientific transparency and evolving research dissemination, with work represented across Scopus-indexed platforms and linked to ORCID for interoperable academic identity management. Although specific award information is not listed, the breadth and depth of his output underscore his dedication to advancing medical research and strengthening the global exchange of scientific knowledge. Overall, Dr. Kaiming Zhang exemplifies a modern clinician-researcher whose work enhances understanding of critical health challenges and contributes meaningfully to improved patient care, research innovation, and societal well-being.
Profiles: Scopus
Featured Publications
1. He, Y., Xing, J., Li, J., Zhang, K., & Li, X. (2025). S100A8 and S100A9-mediated keratinocyte affecting T lymphocyte immune imbalance through TLR4/NF-κB in psoriasis. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-96874-y.
2. Liang, H., Wang, Y., Li, J., & Zhang, K. (2025). Crotonylation deficiency of S100A7 K49 promotes psoriatic keratinocyte proliferation through enhanced interaction with RAGE. Scientific Reports, 15(1), 14678. https://doi.org/10.1038/s41598-025-96874-y.
3. Liang, N., Cao, Y., Li, J., & Zhang, K. (2025). Normal dermal mesenchymal stem cells improve the functions of psoriatic keratinocytes by inducing autophagy. Acta Histochemica, 127(1), 152229. https://doi.org/10.1016/j.acthis.2025.152229.
4. Kuroda, K., Sapadin, A., Shoji, T., Fleischmajer, R., & Lebwohl, M. (2001). Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. Journal of Investigative Dermatology, 116(5), 713–720. https://doi.org/10.1046/j.1523-1747.2001.01316.x.
Cited by 124
Prof. Kaiming Zhang advances the molecular understanding of inflammatory and immune-mediated diseases, uncovering pathways that drive disease progression. His work provides essential foundations for developing targeted therapies and improving clinical outcomes worldwide.